Polymyxin-Resistant Acinetobacter spp. Isolates: What is Next?
Author Information
Author(s): Reis Adriana O., Luz Deise A.M., Tognim Maria C.B., Sader Hélio S., Gales Ana C.
Primary Institution: Universidade Federal de São Paulo
Hypothesis
What is the frequency of occurrence of Acinetobacter spp. strains exhibiting reduced susceptibility to polymyxin B?
Conclusion
The study found that polymyxin B-resistant strains of Acinetobacter spp. have emerged due to antimicrobial selective pressure and the dissemination of clonal strains.
Supporting Evidence
- Resistance rates to carbapenems have increased to approximately 12% or higher in some Brazilian hospitals.
- Five Acinetobacter spp. isolates were found to be resistant to polymyxin B.
- Only one strain was resistant to meropenem, indicating varying susceptibility rates.
- The disk diffusion method was confirmed to be unreliable for detecting Acinetobacter spp. isolates with reduced susceptibility to polymyxins.
Takeaway
Doctors found some germs that don't get killed by a strong medicine called polymyxin B, which means we need to be careful and find new ways to treat infections.
Methodology
The study involved collecting bloodstream isolates of Acinetobacter spp. from a Brazilian hospital and testing their susceptibility to polymyxin B and meropenem using disk diffusion and agar dilution techniques.
Limitations
The study faced limitations in identifying Acinetobacter at the species level and the reliability of the disk diffusion method for detecting polymyxin resistance.
Participant Demographics
The isolates were collected from a tertiary hospital in São Paulo, Brazil.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website